Drug Resistance Conferred by Mutations Outside the Active Site through Alterations in the Dynamic and Structural Ensemble of HIV-1 Protease
about
Effects of Hinge Region Natural Polymorphisms on Human Immunodeficiency Virus-1 Protease Structure, Dynamics and Drug-Pressure EvolutionEffects of drug-resistant mutations on the dynamic properties of HIV-1 protease and inhibition by Amprenavir and Darunavir.Highly resistant HIV-1 proteases and strategies for their inhibition.Structural analyses of 2015-updated drug-resistant mutations in HIV-1 protease: an implication of protease inhibitor cross-resistance.Interdependence of Inhibitor Recognition in HIV-1 Protease.Pulsed EPR characterization of HIV-1 protease conformational sampling and inhibitor-induced population shifts.Improving Viral Protease Inhibitors to Counter Drug Resistance.Decoding HIV resistance: from genotype to therapy.Molecular and Dynamic Mechanism Underlying Drug Resistance in Genotype 3 Hepatitis C NS3/4A Protease.Elucidating the Interdependence of Drug Resistance from Combinations of Mutations.De novo active sites for resurrected Precambrian enzymes.Mutations Proximal to Sites of Autoproteolysis and the α-Helix That Co-evolve under Drug Pressure Modulate the Autoprocessing and Vitality of HIV-1 Protease.The L33F darunavir resistance mutation acts as a molecular anchor reducing the flexibility of the HIV-1 protease 30s and 80s loops.Probing Structural Changes among Analogous Inhibitor-Bound Forms of HIV-1 Protease and a Drug-Resistant Mutant in Solution by Nuclear Magnetic Resonance.Role of Conformational Motions in Enzyme Function: Selected Methodologies and Case Studies.Drug Resistance Mutation L76V Alters Nonpolar Interactions at the Flap-Core Interface of HIV-1 Protease
P2860
Q27727967-0993454F-21E5-423E-BBF2-A7B692D75984Q35650944-06DFCD2E-E2A0-43D1-91CF-F8A85F8E8319Q35907004-DA285442-37BA-4D09-9ABF-71FE02C116B5Q36268829-E8183092-E69C-41DB-AD53-67C232985A9EQ36327966-561F26E4-A4BF-4978-B7ED-9C4B35ED82EDQ36593975-DDF45995-4072-4A94-9598-A7AAFAD460A2Q37017282-7EBB616F-43B3-46E5-8D30-6BD344924027Q38632663-D7428F0E-13D8-4814-A912-22F0166BDD23Q39500905-AC23B82F-FA64-4ABC-B0CB-A554B0B0521CQ40038899-1C1BC896-26A5-4DF9-837A-6A9A8978FE21Q41078215-79FA3662-7370-4973-BC9A-C51B642D5102Q41490002-564D4C66-77A6-44A8-9648-A67173FCDD03Q45345083-910C8520-50BC-4BB5-BE56-C61C012A9A68Q49851708-6052CA2B-A2C7-4EE5-8B8C-0FB4F2A5CE94Q50936015-47C5542E-10C1-457F-886D-ACF77CA1C823Q57063482-1B3906AD-83D9-4F66-A5A1-DF3B34C9DDBB
P2860
Drug Resistance Conferred by Mutations Outside the Active Site through Alterations in the Dynamic and Structural Ensemble of HIV-1 Protease
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Drug Resistance Conferred by M ...... ral Ensemble of HIV-1 Protease
@ast
Drug Resistance Conferred by M ...... ral Ensemble of HIV-1 Protease
@en
Drug Resistance Conferred by M ...... ral Ensemble of HIV-1 Protease
@nl
type
label
Drug Resistance Conferred by M ...... ral Ensemble of HIV-1 Protease
@ast
Drug Resistance Conferred by M ...... ral Ensemble of HIV-1 Protease
@en
Drug Resistance Conferred by M ...... ral Ensemble of HIV-1 Protease
@nl
prefLabel
Drug Resistance Conferred by M ...... ral Ensemble of HIV-1 Protease
@ast
Drug Resistance Conferred by M ...... ral Ensemble of HIV-1 Protease
@en
Drug Resistance Conferred by M ...... ral Ensemble of HIV-1 Protease
@nl
P2093
P2860
P356
P1476
Drug Resistance Conferred by M ...... ral Ensemble of HIV-1 Protease
@en
P2093
Celia A Schiffer
Debra A Ragland
Ellen A Nalivaika
Kristina L Prachanronarong
Madhavi N L Nalam
Nese Kurt-Yilmaz
Rajintha M Bandaranayake
Yufeng Cai
P2860
P304
P356
10.1021/JA504096M
P407
P577
2014-08-27T00:00:00Z